Al Hammadi Company for Development and Investment reported a net profit after zakat and tax of SAR 24.17 million for the first quarter of 2019, down 21.7 percent year-on-year (YoT), due to higher operating expenses related to Nozha hospital, and increased financing costs.
When compared to the previous quarter, net profit increased by 36.55 percent, on higher revenue
Item | Q1 2018 | Q1 2019 | Change |
---|---|---|---|
Revenues | 200.67 | 229.68 | 14.5 % |
Gross Income | 66.84 | 65.60 | (1.9 %) |
Operating Income | 38.29 | 27.20 | (29.0 %) |
Net Income | 30.88 | 24.17 | (21.7 %) |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.19 | 0.15 | (21.7 %) |
Item | Q4 2018 | Q1 2019 | Change |
---|---|---|---|
Revenues | 228.04 | 229.68 | 0.7 % |
Gross Income | 65.32 | 65.60 | 0.4 % |
Operating Income | 29.53 | 27.20 | (7.9 %) |
Net Income | 17.70 | 24.17 | 36.6 % |
Average Shares | 160.00 | 160.00 | - |
EPS (Riyals) | 0.11 | 0.15 | 36.6 % |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | - | - | - | - | - | - |
Q4 2010 | - | - | - | - | - | - |
2010 | 301.55 | (2.7 %) | 136.40 | 8.4 % | 87.88 | 8.6 % |
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 330.66 | 9.7 % | 147.65 | 8.3 % | 92.15 | 4.9 % |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
Q1 2013 | 104.84 | - | 47.34 | - | 30.09 | - |
Q2 2013 | 108.85 | - | 45.84 | - | 22.74 | - |
Q3 2013 | 96.26 | - | 36.81 | - | 19.02 | - |
Q4 2013 | 124.13 | - | 55.17 | - | 34.34 | - |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
Q1 2014 | 122.04 | 16.4 % | 54.71 | 15.6 % | 35.96 | 19.5 % |
Q2 2014 | 121.66 | 11.8 % | 53.68 | 17.1 % | 35.77 | 57.3 % |
Q3 2014 | 108.83 | 13.1 % | 44.74 | 21.5 % | 24.77 | 30.3 % |
Q4 2014 | 129.43 | 4.3 % | 55.99 | 1.5 % | 34.52 | 0.5 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
Q1 2015 | 129.48 | 6.1 % | 50.64 | (7.4 %) | 33.35 | (7.3 %) |
Q2 2015 | 137.36 | 12.9 % | 63.56 | 18.4 % | 37.91 | 6.0 % |
Q3 2015 | 136.80 | 25.7 % | 57.97 | 29.6 % | 31.92 | 28.8 % |
Q4 2015 | 157.70 | 21.8 % | 68.06 | 21.6 % | 40.39 | 17.0 % |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 143.57 | 9.6 % |
Q1 2016 | 144.16 | 11.3 % | 54.75 | 8.1 % | 26.66 | (20.0 %) |
Q2 2016 | 138.08 | 0.5 % | 57.56 | (9.5 %) | 27.63 | (27.1 %) |
Q3 2016 | 141.35 | 3.3 % | 56.48 | (2.6 %) | 25.97 | (18.6 %) |
Q4 2016 | 182.65 | 15.8 % | 73.35 | 7.8 % | 18.58 | (54.0 %) |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 98.81 | (31.2 %) |
Q1 2017 | 180.23 | 25.0 % | 62.02 | 13.3 % | 33.61 | 26.0 % |
Q2 2017 | 176.71 | 28.0 % | 58.16 | 1.0 % | 32.88 | 19.0 % |
Q3 2017 | 163.01 | 15.3 % | 53.91 | (4.5 %) | 26.46 | 1.9 % |
Q4 2017 | 188.69 | 3.3 % | 65.08 | (11.3 %) | 33.93 | 82.6 % |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 126.88 | 28.4 % |
Q1 2018 | 200.67 | 11.3 % | 66.84 | 7.8 % | 38.29 | 13.9 % |
Q2 2018 | 214.49 | 21.4 % | 53.28 | (8.4 %) | 28.26 | (14.0 %) |
Q3 2018 | 250.40 | 53.6 % | 64.92 | 20.4 % | 31.19 | 17.9 % |
Q4 2018 | 228.04 | 20.9 % | 65.32 | 0.4 % | 29.53 | (13.0 %) |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
Q1 2019 | 229.68 | 14.5 % | 65.60 | (1.9 %) | 27.20 | (29.0 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
2009 | 309.88 | - | 125.79 | - | 80.95 | - |
2010 | 301.55 | (2.7 %) | 136.40 | 8.4 % | 87.88 | 8.6 % |
2011 | 330.66 | 9.7 % | 147.65 | 8.3 % | 92.15 | 4.9 % |
2012 | 378.68 | 14.5 % | 163.11 | 10.5 % | 92.34 | 0.2 % |
2013 | 434.08 | 14.6 % | 185.16 | 13.5 % | 112.10 | 21.4 % |
2014 | 481.96 | 11.0 % | 209.11 | 12.9 % | 130.95 | 16.8 % |
2015 | 561.33 | 16.5 % | 240.24 | 14.9 % | 143.57 | 9.6 % |
2016 | 606.24 | 8.0 % | 242.13 | 0.8 % | 98.81 | (31.2 %) |
2017 | 708.62 | 16.9 % | 239.16 | (1.2 %) | 126.88 | 28.4 % |
2018 | 893.60 | 26.1 % | 250.36 | 4.7 % | 127.27 | 0.3 % |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2010 | - | - | - | - | - | - |
Q2 2010 | - | - | - | - | - | - |
Q3 2010 | - | - | - | - | - | - |
Q4 2010 | - | - | - | - | - | - |
2010 | 79.87 | 4.5 % | 0.50 | - | 79.87 | 0.50 |
Q1 2011 | - | - | - | - | - | - |
Q2 2011 | - | - | - | - | - | - |
Q3 2011 | - | - | - | - | - | - |
Q4 2011 | - | - | - | - | - | - |
2011 | 89.94 | 12.6 % | 0.56 | - | 89.94 | 0.56 |
Q1 2012 | - | - | - | - | - | - |
Q2 2012 | - | - | - | - | - | - |
Q3 2012 | - | - | - | - | - | - |
Q4 2012 | - | - | - | - | - | - |
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
Q1 2013 | 29.83 | - | 0.19 | - | 29.83 | 0.19 |
Q2 2013 | 30.06 | - | 0.19 | - | 24.06 | 0.15 |
Q3 2013 | 18.32 | - | 0.11 | - | 18.32 | 0.11 |
Q4 2013 | 33.29 | - | 0.21 | - | 33.29 | 0.21 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
Q1 2014 | 34.23 | 14.7 % | 0.21 | - | 34.23 | 0.21 |
Q2 2014 | 35.60 | 18.4 % | 0.22 | - | 35.60 | 0.22 |
Q3 2014 | 25.42 | 38.7 % | 0.16 | - | 25.42 | 0.16 |
Q4 2014 | 33.71 | 1.2 % | 0.21 | - | 33.71 | 0.21 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
Q1 2015 | 41.01 | 19.8 % | 0.26 | 9.80 | 31.21 | 0.20 |
Q2 2015 | 36.89 | 3.6 % | 0.23 | - | 36.89 | 0.23 |
Q3 2015 | 27.69 | 8.9 % | 0.17 | - | 27.69 | 0.17 |
Q4 2015 | 35.75 | 6.0 % | 0.22 | - | 35.75 | 0.22 |
2015 | 141.33 | 9.6 % | 0.88 | 9.80 | 131.53 | 0.82 |
Q1 2016 | 21.14 | (48.5 %) | 0.13 | - | 21.14 | 0.13 |
Q2 2016 | 20.63 | (44.1 %) | 0.13 | - | 20.63 | 0.13 |
Q3 2016 | 20.73 | (25.1 %) | 0.13 | - | 20.73 | 0.13 |
Q4 2016 | 10.48 | (70.7 %) | 0.07 | - | 10.48 | 0.07 |
2016 | 72.96 | (48.4 %) | 0.46 | - | 72.96 | 0.46 |
Q1 2017 | 27.97 | 32.3 % | 0.17 | - | 27.97 | 0.17 |
Q2 2017 | 25.66 | 24.4 % | 0.16 | - | 25.66 | 0.16 |
Q3 2017 | 23.59 | 13.8 % | 0.15 | - | 23.59 | 0.15 |
Q4 2017 | 30.76 | 193.4 % | 0.19 | - | 30.76 | 0.19 |
2017 | 107.97 | 48.0 % | 0.67 | - | 107.97 | 0.67 |
Q1 2018 | 30.88 | 10.4 % | 0.19 | - | 30.88 | 0.19 |
Q2 2018 | 19.93 | (22.3 %) | 0.12 | - | 19.93 | 0.12 |
Q3 2018 | 21.31 | (9.7 %) | 0.13 | - | 21.31 | 0.13 |
Q4 2018 | 17.70 | (42.5 %) | 0.11 | - | 17.70 | 0.11 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
Q1 2019 | 24.17 | (21.7 %) | 0.15 | - | 24.17 | 0.15 |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
2009 | 76.40 | - | 0.48 | - | 76.40 | 0.48 |
2010 | 79.87 | 4.5 % | 0.50 | - | 79.87 | 0.50 |
2011 | 89.94 | 12.6 % | 0.56 | - | 89.94 | 0.56 |
2012 | 94.27 | 4.8 % | 0.59 | - | 94.27 | 0.59 |
2013 | 111.50 | 18.3 % | 0.70 | - | 111.50 | 0.70 |
2014 | 128.95 | 15.6 % | 0.81 | - | 128.95 | 0.81 |
2015 | 141.33 | 9.6 % | 0.88 | 9.80 | 131.53 | 0.82 |
2016 | 72.96 | (48.4 %) | 0.46 | - | 72.96 | 0.46 |
2017 | 107.97 | 48.0 % | 0.67 | - | 107.97 | 0.67 |
2018 | 89.81 | (16.8 %) | 0.56 | - | 89.81 | 0.56 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
2010 | 45.23 % | 33.73 % | 26.49 % |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
2011 | 44.65 % | 31.79 % | 27.20 % |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
2012 | 43.07 % | 27.97 % | 24.89 % |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | 42.66 % | 27.60 % | 24.31 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
Q1 2014 | 42.66 % | 27.85 % | 24.35 % |
Q2 2014 | 43.18 % | 29.90 % | 26.17 % |
Q3 2014 | 43.70 % | 30.34 % | 26.97 % |
Q4 2014 | 43.39 % | 30.09 % | 26.75 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
Q1 2015 | 41.90 % | 29.13 % | 25.73 % |
Q2 2015 | 42.55 % | 28.68 % | 25.19 % |
Q3 2015 | 42.80 % | 29.71 % | 24.29 % |
Q4 2015 | 42.80 % | 31.06 % | 23.43 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
Q1 2016 | 42.42 % | 30.79 % | 21.09 % |
Q2 2016 | 41.32 % | 30.64 % | 18.24 % |
Q3 2016 | 40.74 % | 29.96 % | 16.90 % |
Q4 2016 | 39.94 % | 25.11 % | 12.04 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
Q1 2017 | 38.83 % | 24.74 % | 12.43 % |
Q2 2017 | 36.71 % | 24.09 % | 12.46 % |
Q3 2017 | 35.22 % | 23.41 % | 12.48 % |
Q4 2017 | 33.75 % | 25.39 % | 15.24 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
Q1 2018 | 33.46 % | 26.03 % | 15.21 % |
Q2 2018 | 31.18 % | 25.45 % | 13.71 % |
Q3 2018 | 29.28 % | 24.60 % | 12.04 % |
Q4 2018 | 28.02 % | 24.14 % | 10.05 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
Q1 2019 | 27.00 % | 22.96 % | 9.01 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
2009 | 40.59 % | 31.76 % | 24.65 % |
2010 | 45.23 % | 33.73 % | 26.49 % |
2011 | 44.65 % | 31.79 % | 27.20 % |
2012 | 43.07 % | 27.97 % | 24.89 % |
2013 | 42.66 % | 28.96 % | 25.69 % |
2014 | 43.39 % | 30.07 % | 26.75 % |
2015 | 42.80 % | 31.06 % | 23.43 % |
2016 | 39.94 % | 25.10 % | 12.03 % |
2017 | 33.75 % | 25.39 % | 15.24 % |
2018 | 28.02 % | 24.14 % | 10.05 % |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | 45.15 % | 31.89 % | 28.45 % |
Q2 2013 | 42.11 % | 24.00 % | 22.10 % |
Q3 2013 | 38.24 % | 23.34 % | 19.03 % |
Q4 2013 | 44.45 % | 30.42 % | 26.82 % |
Q1 2014 | 44.83 % | 32.21 % | 28.04 % |
Q2 2014 | 44.12 % | 32.25 % | 29.26 % |
Q3 2014 | 41.11 % | 26.05 % | 23.36 % |
Q4 2014 | 43.26 % | 29.45 % | 26.04 % |
Q1 2015 | 39.11 % | 28.49 % | 24.10 % |
Q2 2015 | 46.28 % | 30.21 % | 26.86 % |
Q3 2015 | 42.37 % | 30.62 % | 20.24 % |
Q4 2015 | 43.16 % | 34.31 % | 22.67 % |
Q1 2016 | 37.98 % | 27.65 % | 14.66 % |
Q2 2016 | 41.68 % | 29.60 % | 14.94 % |
Q3 2016 | 39.95 % | 27.83 % | 14.67 % |
Q4 2016 | 40.16 % | 17.59 % | 5.74 % |
Q1 2017 | 34.41 % | 25.82 % | 15.52 % |
Q2 2017 | 32.91 % | 26.06 % | 14.52 % |
Q3 2017 | 33.07 % | 24.41 % | 14.47 % |
Q4 2017 | 34.49 % | 25.21 % | 16.30 % |
Q1 2018 | 33.31 % | 28.10 % | 15.39 % |
Q2 2018 | 24.84 % | 23.98 % | 9.29 % |
Q3 2018 | 25.93 % | 21.86 % | 8.51 % |
Q4 2018 | 28.65 % | 23.30 % | 7.76 % |
Q1 2019 | 28.56 % | 22.87 % | 10.52 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2010 | - | - | - | - |
Q2 2010 | - | - | - | - |
Q3 2010 | - | - | - | - |
Q4 2010 | - | - | - | - |
Q1 2011 | - | - | - | - |
Q2 2011 | - | - | - | - |
Q3 2011 | - | - | - | - |
Q4 2011 | - | - | - | - |
Q1 2012 | - | - | - | - |
Q2 2012 | - | - | - | - |
Q3 2012 | - | - | - | - |
Q4 2012 | - | - | - | - |
Q1 2013 | 160.00 | - | - | 3.74 |
Q2 2013 | 160.00 | - | - | 3.67 |
Q3 2013 | 160.00 | - | - | 3.78 |
Q4 2013 | 160.00 | 0.70 | 0.66 | 3.66 |
Q1 2014 | 160.00 | 0.72 | 0.69 | 3.87 |
Q2 2014 | 160.00 | 0.76 | 0.76 | 7.88 |
Q3 2014 | 160.00 | 0.80 | 0.80 | 8.04 |
Q4 2014 | 160.00 | 0.81 | 0.81 | 8.25 |
Q1 2015 | 160.00 | 0.85 | 0.79 | 8.51 |
Q2 2015 | 160.00 | 0.86 | 0.80 | 8.27 |
Q3 2015 | 160.00 | 0.87 | 0.81 | 8.44 |
Q4 2015 | 160.00 | 0.88 | 0.82 | 8.66 |
Q1 2016 | 160.00 | 0.76 | 0.76 | 8.80 |
Q2 2016 | 160.00 | 0.66 | 0.66 | 8.37 |
Q3 2016 | 160.00 | 0.61 | 0.61 | 8.50 |
Q4 2016 | 160.00 | 0.46 | 0.46 | 8.56 |
Q1 2017 | 160.00 | 0.50 | 0.50 | 8.75 |
Q2 2017 | 160.00 | 0.53 | 0.53 | 8.89 |
Q3 2017 | 160.00 | 0.55 | 0.55 | 9.04 |
Q4 2017 | 160.00 | 0.67 | 0.67 | 8.67 |
Q1 2018 | 160.00 | 0.69 | 0.69 | 8.85 |
Q2 2018 | 160.00 | 0.66 | 0.66 | 8.98 |
Q3 2018 | 160.00 | 0.64 | 0.64 | 9.11 |
Q4 2018 | 160.00 | 0.56 | 0.56 | 9.24 |
Q1 2019 | 160.00 | 0.52 | 0.52 | 9.40 |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
2009 | 160.00 | 0.48 | 0.48 | 2.35 |
2010 | 160.00 | 0.50 | 0.50 | 2.78 |
2011 | 160.00 | 0.56 | 0.56 | 2.96 |
2012 | 160.00 | 0.59 | 0.59 | 3.55 |
2013 | 160.00 | 0.70 | 0.70 | 3.66 |
2014 | 160.00 | 0.81 | 0.81 | 8.25 |
2015 | 160.00 | 0.88 | 0.82 | 8.66 |
2016 | 160.00 | 0.46 | 0.46 | 8.56 |
2017 | 160.00 | 0.67 | 0.67 | 8.67 |
2018 | 160.00 | 0.56 | 0.56 | 9.24 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2010 | - | - | - |
Q2 2010 | - | - | - |
Q3 2010 | - | - | - |
Q4 2010 | - | - | - |
Q1 2011 | - | - | - |
Q2 2011 | - | - | - |
Q3 2011 | - | - | - |
Q4 2011 | - | - | - |
Q1 2012 | - | - | - |
Q2 2012 | - | - | - |
Q3 2012 | - | - | - |
Q4 2012 | - | - | - |
Q1 2013 | - | - | - |
Q2 2013 | - | - | - |
Q3 2013 | - | - | - |
Q4 2013 | - | - | - |
Q1 2014 | - | - | - |
Q2 2014 | - | - | - |
Q3 2014 | 51.42 | 51.42 | 5.14 |
Q4 2014 | 48.92 | 48.92 | 4.78 |
Q1 2015 | 51.53 | 55.54 | 5.14 |
Q2 2015 | 54.13 | 58.30 | 5.61 |
Q3 2015 | 44.33 | 47.69 | 4.57 |
Q4 2015 | 41.63 | 44.73 | 4.24 |
Q1 2016 | 36.41 | 36.41 | 3.14 |
Q2 2016 | 45.86 | 45.86 | 3.60 |
Q3 2016 | 36.32 | 36.32 | 2.62 |
Q4 2016 | 68.31 | 68.31 | 3.64 |
Q1 2017 | 61.37 | 61.37 | 3.50 |
Q2 2017 | 58.51 | 58.51 | 3.49 |
Q3 2017 | 47.94 | 47.94 | 2.91 |
Q4 2017 | 41.25 | 41.25 | 3.21 |
Q1 2018 | 39.28 | 39.28 | 3.07 |
Q2 2018 | 37.68 | 37.68 | 2.76 |
Q3 2018 | 32.21 | 32.21 | 2.27 |
Q4 2018 | 33.55 | 33.55 | 2.04 |
Q1 2019 | 35.91 | 35.91 | 1.98 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
2009 | - | - | - |
2010 | - | - | - |
2011 | - | - | - |
2012 | - | - | - |
2013 | - | - | - |
2014 | 48.92 | 48.92 | 4.78 |
2015 | 41.63 | 44.73 | 4.24 |
2016 | 68.34 | 68.34 | 3.64 |
2017 | 41.25 | 41.25 | 3.21 |
2018 | 33.55 | 33.55 | 2.04 |
Q1 2019
2019
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
Q1 2017 | 150.74 | 29.49 |
Q2 2017 | 147.45 | 29.26 |
Q3 2017 | 136.70 | 26.31 |
Q4 2017 | 155.95 | 32.73 |
Q1 2018 | 140.85 | 59.82 |
Q2 2018 | 143.64 | 71.39 |
Q3 2018 | 140.83 | 109.03 |
Q4 2018 | 154.81 | 73.23 |
Q1 2019 | 146.91 | 82.77 |
Period | healthy services and other | Pharmaceutical sales revenue - Pharmacies |
---|---|---|
2010 | 224.05 | 77.50 |
2011 | 244.33 | 86.33 |
2012 | 274.90 | 103.78 |
2013 | 317.00 | 117.11 |
2014 | 360.30 | 121.61 |
2015 | 451.60 | 109.71 |
2016 | 552.40 | 89.11 |
2017 | 590.84 | 117.78 |
2018 | 580.13 | 313.47 |
Item | Q1 2019 (e) | Q1 2019 (a) | Change |
---|---|---|---|
Average | 23.80 | 24.17 | 1.56 % |
Item | Q1 2019 (e) | Q1 2019 (a) | Change |
---|---|---|---|
Sico | 23.00 | 24.17 | 5.1 % |
AlJazira Capital | 21.20 | 24.17 | 14.0 % |
Al Rajhi Capital | 20.00 | 24.17 | 20.9 % |
SNB Capital | 31.00 | 24.17 | (22.0) % |
Current | |
Market Cap (M Riyal) | 7,432.00 |
Enterprise Value (EV) (M) | 7,372.52 |
Shares Outstanding ((M)) | 160.00 |
EPS ( Riyal) (TTM) | 2.01 |
Book Value (BV) ( Riyal) | 11.97 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 28.56 |
P/E (TTM) | 23.08 |
Price/book | 3.88 |
Return on Average Assets (%) (TTM) | 12.5 |
Return on Average Equity (%) (TTM) | 17.5 |
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}